HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 1038795Generated: October 31, 2026
Tert-butyl (piperidin-4-ylmethyl)carbamate → Tert-butyl (1-(2-chlorofuro[3,2-d]pyrimidin-4-yl)piperidin-4-yl)methylcarbamate
https://huagongshe.com/reaction/1038795
Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Tert-butyl (piperidin-4-ylmethyl)carbamate | HCID 723429 | — |
| Reactant | 2,4-Dichlorofuro[3,2-D]pyrimidine | HCID 45789968 | — |
| Reactant | Tert-butyl(1-(2-(4-sulfamoylphenylamino)furo[3,2-d]pyrimidin-4-yl)piperidin-4-yl)methylcarbamate | HCID 70143000 | — |
| Product | Tert-butyl (1-(2-chlorofuro[3,2-d]pyrimidin-4-yl)piperidin-4-yl)methylcarbamate | HCID 86665090 | — |
Reaction Steps
The precursor to Example #C.1, tert-butyl (1-(2-(4-sulfamoylphenylamino)furo[3,2-d]pyrimidin-4-yl)piperidin-4-yl)methylcarbamate, was prepared as shown in Scheme B. 2,4-Dichlorofuro[3,2-d]pyrimidine [Ark Pharm] and tert-butyl piperidin-4-ylmethylcarbamate [Astatech] are reacted following conditions given in General Procedure A to give tert-butyl (1-(2-chlorofuro[3,2-d]pyrimidin-4-yl)piperidin-4-yl)methylcarbamate. The intermediate is then reacted with 4-aminobenzenesulfonamide using the conditions described in General Procedure B to give the precursor to Example #C.1. The reaction sequence detailed above is translated in the preparations and examples section to “prepared using A from 2,4-dichlorofuro[3,2-d]pyrimidine [ArkPharm] with tert-butyl piperidin-4-ylmethylcarbamate [Astatech] and B with 4-aminobenzenesulfonamide.”
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US08551981B2 |
|---|
| Source dataset | uspto-grants-2013_10 |
|---|
| ORD ID | ord-d6c016dc052f4821b828c589137ce415 |
|---|
| Source note | uspto-grants-2013_10 |
|---|